Van der Boechorststraat 7
Afdeling MMI Kamer B-340
1081 BT Amsterdam
The Netherlands
T +31 20 444 8307
info@microbiome.nl
Nederlands English

About us

Microbiome is leading in the field of innovative molecular microbiological diagnostics. read more >

Diseases

Finding innovative solutions to medical problems drives us. read more >

Products

Microbiome is active in the discovery, development, manufacturing
and marketing of innovative molecular microbiological
diagnostics of infectious diseases.
 

M. tuberculosis PCR Assay

The RealAccurate Mycobacterium tuberculosis PCR kit is a Real Time PCR test enabling detection of small amounts of Mycobacterium tuberculosis complex DNA by targeting the multicopy target IS6110 insertion element. Additionally, the kit includes a competitive amplification control of a modified Mycobacterium smegmatis strain.

 

read more >

Presto CT/NG Assay

Microbiome has developed a unique test that can detect Chlamydia trachomatis and N. gonorrhoeae in all their variants. There is no test in the market that can do this. Furthermore, the Presto kit is much more sensitive and specific than other commercial chlamydia or gonorrhoeae tests.
 

read more >

HPV E6/E7 Assay

The HPV Test of Microbiome is one of the leading CE/IVD approved HPV test that directly detects the presence of high-risk types of the HPV virus.

read more >

Latest news

As Tuberculosis Grows More Difficult to Control, Vaccine Candidate to Prevent Disease Enters Clinical Testing

Aeras and the Infectious Disease Research Institute (IDRI) announce today the start of the first clinical trial of IDRI's novel tuberculosis vaccine candidate,... read more >

Growing Resistance to Gonorrhea Treatment

Recent research explains why treating gonorrhea has grown more difficult. Scientists from Harvard University, the Centers for Disease Control and Prevention... read more >

Partners of Microbiome

We develop integrated solutions together with leading manufacturers from the diagnostics and pharmaceutical industries, helping them to leverage our leading sample & assay technologies as part of their own offerings. read more >